IRIS
VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.255
AS - Asia 5.088
NA - Nord America 3.016
SA - Sud America 1.559
AF - Africa 117
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.052
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.076
US - Stati Uniti d'America 2.856
SG - Singapore 1.767
CN - Cina 1.528
BR - Brasile 1.295
HK - Hong Kong 748
SE - Svezia 637
IT - Italia 614
VN - Vietnam 567
FR - Francia 267
DE - Germania 201
GB - Regno Unito 103
AR - Argentina 97
BD - Bangladesh 77
IN - India 77
FI - Finlandia 72
NL - Olanda 66
CA - Canada 65
JP - Giappone 61
AT - Austria 57
EC - Ecuador 57
MX - Messico 53
ID - Indonesia 41
IQ - Iraq 38
ZA - Sudafrica 38
CO - Colombia 31
PL - Polonia 31
TR - Turchia 30
PK - Pakistan 25
PY - Paraguay 25
ES - Italia 23
IE - Irlanda 19
UZ - Uzbekistan 19
SA - Arabia Saudita 18
CL - Cile 17
TN - Tunisia 17
VE - Venezuela 17
MA - Marocco 16
AU - Australia 15
UA - Ucraina 15
DZ - Algeria 13
IR - Iran 12
JM - Giamaica 12
EG - Egitto 11
HU - Ungheria 11
BE - Belgio 10
MY - Malesia 10
KE - Kenya 9
PE - Perù 9
CH - Svizzera 8
LT - Lituania 8
HN - Honduras 7
PH - Filippine 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
LB - Libano 6
AZ - Azerbaigian 5
IL - Israele 5
JO - Giordania 5
KW - Kuwait 5
KZ - Kazakistan 5
NI - Nicaragua 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
KR - Corea 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GH - Ghana 1
Totale 15.040
Salva come PNG Salva come JPEG
Città #
Singapore 803
Hong Kong 674
Moscow 654
Dallas 390
Ashburn 381
San Jose 340
Shanghai 330
Hefei 252
Lawrence 225
Princeton 225
Lauterbourg 223
Ho Chi Minh City 212
Milan 188
Beijing 186
New York 129
São Paulo 128
Hanoi 106
Los Angeles 67
Nuremberg 62
Helsinki 43
Santa Clara 38
Boardman 35
Rio de Janeiro 34
Tokyo 32
Orem 31
Rome 30
Denver 29
Munich 29
Brasília 28
Guangzhou 28
Belo Horizonte 26
Da Nang 26
Vienna 26
Haiphong 25
Warsaw 24
Johannesburg 23
Atlanta 22
Brooklyn 22
Montreal 22
Quito 22
Cesano Boscone 21
Chennai 20
Guayaquil 20
Stockholm 20
Curitiba 19
Dublin 19
Poplar 18
London 17
Tianjin 17
Baghdad 16
Manchester 16
Mexico City 16
Tashkent 16
Turku 16
Houston 15
Shenzhen 15
Council Bluffs 14
Frankfurt am Main 14
Hải Dương 14
Salvador 14
Washington 14
Amsterdam 13
Bergamo 13
Chicago 13
Phoenix 13
Toronto 13
Ankara 12
Bologna 12
Campinas 12
Porto Alegre 12
Caxias do Sul 11
Hangzhou 11
Lappeenranta 11
Recife 11
San Francisco 11
Seattle 11
Bolzano 10
Chaoyang 10
Dhaka 10
Duque de Caxias 10
Naples 10
Nova Iguaçu 10
Shijiazhuang 10
Turin 10
Budapest 9
Buffalo 9
Guarulhos 9
Ninh Bình 9
Reston 9
São Gonçalo 9
Uberlândia 9
Aracaju 8
Baltimore 8
Biên Hòa 8
Bogotá 8
Buenos Aires 8
Can Tho 8
Fortaleza 8
Franca 8
Kingston 8
Totale 6.915
Salva come PNG Salva come JPEG
Nome #
Loss of mismatched HLA in leukemia after stem-cell transplantation 200
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 176
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 167
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 167
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 166
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 160
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 148
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 139
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 137
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 136
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 125
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 124
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 120
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 118
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 117
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 116
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 115
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 110
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 106
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 105
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 104
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 102
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia 99
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 99
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 99
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 98
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 97
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 97
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 94
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 94
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 92
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 91
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 90
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 90
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 89
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 87
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 87
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 85
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 85
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 84
An Accelerated CD8+, but Not CD4+, T -Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 84
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 84
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 83
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 83
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 83
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 82
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 80
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 80
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? 79
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 79
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 79
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 76
Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients 76
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 75
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 75
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report 74
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 74
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 74
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 73
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 72
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 72
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 72
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 71
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 70
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 69
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 68
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 68
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 68
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 67
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 66
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience 66
Experts' considerations on HLA-haploidentical stem cell transplantation 65
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 65
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 63
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 63
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 62
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 62
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 62
Tracking genetically engineered lymphocytes long-term reveals the dynamic of T-cell immunological memory 62
Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation 62
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 61
Improving the safety of cell therapy with the TK-suicide gene. 61
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 61
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 61
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 61
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation 61
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 61
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 60
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 60
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes 60
Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3 59
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation 58
DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION 58
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation 57
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T EMRA lymphocytes 57
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 57
POST-TRANSPLANT CYCLOPHOSPHAMIDE ELIMINATES MATURE DONOR NK CELLS, DAMPENING NATURAL KILLER CELL ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION 57
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 56
Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse 56
DROPLET DIGITAL PCR FOR DNMT3A AND IDH1/2 MUTATIONS TO IMPROVE EARLY DETECTION OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HSCT 56
Totale 8.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024670 32 29 61 66 44 87 106 56 12 23 30 124
2024/20253.424 429 66 62 86 89 256 431 390 614 510 240 251
2025/20269.646 740 755 732 1.540 668 266 778 651 2.790 418 197 111
Totale 15.351